missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Human Inhibin A, Carrier-Free Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Brand:  R&D Systems™ 8506-AB-010/CF

Encompass

Product Code. 15770224

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
View alternative products »

This item is not returnable. View return policy

Description

Description

The Recombinant Human Inhibin A Protein is derived from CHO. The Recombinant Human Inhibin A Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

P05111 (alpha chain) & P08476 (beta chain)
Observed M.W.: 12-25kDa, reducing conditions, Theoretical M.W.: 15kDa (alpha chain) & 13kDa (beta chain)
Chinese Hamster Ovary cell line,CHO-derived human Inhibin A protein Ser233-Ile366 (alpha chain) & Gly311-Ser426 (beta chain)
<0.10 EU per 1μg of the protein by the LAL method.
Inhibin alpha
Measured by its ability to neutralize Activin-mediated erythroid differentiation of K562 human chronic myelogenous leukemia cells. The ED50 for this effect is typically 3-18ng/mL.
Yes
3623
10μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
A-inhibin subunit, INHA, Inhibin A, inhibin alpha chain, inhibin, alpha
INHA
Unconjugated
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.